Pierre Brugières
University of Paris
130 Papers
861 Citations
Pierre Brugières is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Transcranial magnetic stimulation. The author has an hindex of 38, co-authored 127 publications. Previous affiliations of Pierre Brugières include Centre hospitalier universitaire Henri-Mondor & French Institute of Health and Medical Research.
Chat about Author
Papers
Liver Cirrhosis: Intravoxel Incoherent Motion MR Imaging—Pilot Study
Alain Luciani,Alexandre Vignaud,Madeleine Cavet,Jeanne Tran Van Nhieu,Ariane Mallat,Lucile Ruel,Alexis Laurent,Jean-François Deux,Pierre Brugières,Alain Rahmouni +9 more
TL;DR: Restricted diffusion observed in patients with cirrhosis may be related to D* variations, which reflect decreased perfusion, as well as alterations in pure molecular water diffusion in cirrhotic livers.
645
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.
Anne-Catherine Bachoud-Lévi,Philippe Remy,Jean-Paul Nǵuyen,Pierre Brugières,Jean-Pascal Lefaucheur,Catherine Bourdet,Sophie Baudic,Véronique Gaura,Patrick Maison,Bassam Haddad,Marie-Françoise Boissé,Thierry Grandmougin,Roland Jeny,Paolo Bartolomeo,Gianfranco Dalla Barba,Jean-Denis Degos,Fabrice Lisovoski,Anne-Marie Ergis,Edwige Pailhous,Pierre Cesaro,Philippe Hantraye,Marc Peschanski +21 more
TL;DR: Fetal neural allografts could be associated with functional, motor, and cognitive improvements in patients with Huntington's disease and were seen in daily-life activities in three of five patients.
480
Zika Virus Associated with Meningoencephalitis
Guillaume Carteaux,Marianne Maquart,Alexandre Bedet,Damien Contou,Pierre Brugières,Slim Fourati,Laurent Cleret de Langavant,Thomas de Broucker,Christian Brun-Buisson,Isabelle Leparc-Goffart,Armand Mekontso Dessap +10 more
TL;DR: An 81-year-old man is found to have Zika virus–associated meningoencephalitis, and the associated clinical syndromes need to be defined.
477
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stéphane Palfi,Jean Marc Gurruchaga,G. Scott Ralph,Helene Lepetit,Sonia Lavisse,Philip C. Buttery,Colin Watts,James Miskin,Michelle Kelleher,Sarah Deeley,Hirokazu Iwamuro,Jean Pascal Lefaucheur,Claire Thiriez,Gilles Fénelon,Gilles Fénelon,Cherry Lucas,Pierre Brugières,Inanna Gabriel,Kou Abhay,Xavier Drouot,Naoki Tani,Aurélie Kas,Bijan Ghaleh,Philippe Le Corvoisier,Patrice Dolphin,David P. Breen,Sarah L Mason,Natalie Valle Guzman,Nicholas D. Mazarakis,Pippa A Radcliffe,Richard Harrop,Susan M. Kingsman,Olivier Rascol,Stuart Naylor,Roger A. Barker,Philippe Hantraye,Philippe Remy,Philippe Remy,Pierre Cesaro,Pierre Cesaro,Kyriacos A. Mitrophanous +40 more
TL;DR: ProSavin was safe and well tolerated in patients with advanced Parkinson's disease and a significant improvement in mean UPDRS part III motor scores off medication was recorded in all patients at 6 months and 12 months.
439
Chronic motor cortex stimulation in the treatment of central and neuropathic pain. Correlations between clinical, electrophysiological and anatomical data.
Jean-Paul Nguyen,Jean-Pascal Lefaucheur,P. Decq,Takuya Uchiyama,Alexandre Carpentier,Denis Fontaine,Pierre Brugières,B. Pollin,Annaick Fève,Sylvie Rostaing,Pierre Cesaro,Yves Keravel +11 more
TL;DR: The neuronavigator localisation and guidance technique proved to be most useful identifying the appropriate portion of the motor gyrus which allowed the establishment of reliable correlations between electrophysiological-clinical and anatomical data which may be used to improve the clinical results and possibly to extend the indications of this technique.
405